All lobbying filings

INNOVATIVE FEDERAL STRATEGIES, LLC

Lobbying for ACURX PHARMACEUTICALS, INC. · biopharmaceutical company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · New York · House · Senate · $30,000.00 income · posted Jul 20, 2026

Official filing document

Bills named in this filing 1

HR 9260
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027

Lobbying activity 1

Budget/Appropriations

H.R.9260/S.____, Departments of Labor, Health and Human Services, Education, and Related Agencies Appropriations bill, 2027, Title II, all provisions related research and clinical trials for the development of antibiotics for infections caused by bacteria listed as priority pathogens.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.